<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Purinergic Signal</journal-id>
      <journal-title>Purinergic Signalling</journal-title>
      <issn pub-type="ppub">1573-9538</issn>
      <issn pub-type="epub">1573-9546</issn>
      <publisher>
        <publisher-name>Springer Netherlands</publisher-name>
        <publisher-loc>Dordrecht</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18404479</article-id>
      <article-id pub-id-type="pmc">2096640</article-id>
      <article-id pub-id-type="publisher-id">9001</article-id>
      <article-id pub-id-type="doi">10.1007/s11302-006-9001-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>E-NTPDases in human airways: Regulation and relevance for chronic lung diseases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Burch</surname>
            <given-names>Lauranell H.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Picher</surname>
            <given-names>Maryse</given-names>
          </name>
          <address>
            <email>pichm@med.unc.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Laboratory of Respiratory Biology, National Institute of Environmental Health Sciences, Research Triangle Park, Durham, North Carolina USA </aff>
        <aff id="Aff2"><label>2</label>Cystic Fibrosis/Pulmonary Research and Treatment Center, School of Medicine, University of North Carolina, 7010 Thurston-Bowles Building, Chapel Hill, NC 27599 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>5</month>
        <year>2006</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2006</year>
      </pub-date>
      <volume>2</volume>
      <issue>2</issue>
      <fpage>399</fpage>
      <lpage>408</lpage>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>1</month>
          <year>2005</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>12</month>
          <year>2005</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Springer Science + Business Media B.V. 2006</copyright-statement>
      </permissions>
      <abstract xml:lang="EN">
        <p>Chronic obstructive lung diseases are characterized by the inability to prevent bacterial infection and a gradual loss of lung function caused by recurrent inflammatory responses. In the past decade, numerous studies have demonstrated the importance of nucleotide-mediated bacterial clearance. Their interaction with P2 receptors on airway epithelia provides a rapid &#x2018;on-and-off&#x2019; signal stimulating mucus secretion, cilia beating activity and surface hydration. On the other hand, abnormally high ATP levels resulting from damaged epithelia and bacterial lysis may cause lung edema and exacerbate inflammatory responses. Airway ATP concentrations are regulated by ecto nucleoside triphosphate diphosphohydrolases (E-NTPDases) which are expressed on the mucosal surface and catalyze the sequential dephosphorylation of nucleoside triphosphates to nucleoside monophosphates (ATP &#x2192; ADP &#x2192; AMP). The common bacterial product, <italic>Pseudomonas aeruginosa</italic> lipopolysaccharide (LPS), induces an acute reduction in azide-sensitive E-NTPDase activities, followed by a sustained increase in activity as well as NTPDase 1 and NTPDase 3 expression. Accordingly, chronic lung diseases, including cystic fibrosis (CF) and primary ciliary dyskinesia, are characterized by higher rates of nucleotide elimination, azide-sensitive E-NTPDase activities and expression. This review integrates the biphasic regulation of airway E-NTPDases with the function of purine signaling in lung diseases. During acute insults, a transient reduction in E-NTPDase activities may be beneficial to stimulate ATP-mediated bacterial clearance. In chronic lung diseases, elevating E-NTPDase activities may represent an attempt to prevent P2 receptor desensitization and nucleotide-mediated lung damage.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>apyrase</kwd>
        <kwd>bacterial clearance</kwd>
        <kwd>CD39</kwd>
        <kwd>chrosobstructive lung diseases</kwd>
        <kwd>diphosphohydrolase</kwd>
        <kwd>endotoxin</kwd>
        <kwd>purinergic signaling</kwd>
        <kwd>oxidative stress</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media, Inc. 2006</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Airway epithelia constitute an essential protective barrier against lung infection, coordinating luminal and interstitial responses to inhaled pathogens through signals (growth factors, cytokines and nucleotides) provided by epithelial, inflammatory and immune cells [<xref ref-type="bibr" rid="CR1">1</xref>]. It is now widely accepted that extracellular nucleotides provide an elaborated cell communication system in mammalian tissues [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>] including the airways [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Each signaling event constitutes a brief &#x2018;on-and-off&#x2019; switch mechanism allowing the target cells to perceive the subsequent signal. The major source of extracellular nucleotides in normal airways is the epithelium, releasing ATP under resting conditions and in response to mechanical or osmotic stress [<xref ref-type="bibr" rid="CR6">6</xref>]. While basal ATP concentrations maintained under resting conditions are insufficient to activate surface receptors, the levels reached near the site of stimulated release initiate a variety of P2 receptor-mediated responses [<xref ref-type="bibr" rid="CR7">7</xref>]. Two P2 receptor families have been identified: Fast-acting (ionotropic) P2X ligand-gated cation channels and slow-acting (metabotropic) G protein-coupled P2Y receptors [<xref ref-type="bibr" rid="CR8">8</xref>]. Although ATP activates members of both families, P2X receptors generally respond to higher concentrations (EC<sub>50</sub> = 1&#x2013;10 &#xB5;M) than P2Y receptors (EC<sub>50</sub> = 0.1&#x2013;1.0 &#xB5;M). Each signal is promptly terminated by surface conversion of ATP to adenosine [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>] and dispersal into the interstitial fluid. Adenosine also initiates cellular responses through P1 (A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub> or A<sub>3</sub>) surface receptors [<xref ref-type="bibr" rid="CR11">11</xref>]. In the airways, nucleotide- and adenosine-mediated communications are involved in wound healing [<xref ref-type="bibr" rid="CR4">4</xref>], bacterial clearance [<xref ref-type="bibr" rid="CR12">12</xref>] and inflammatory responses [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p>
      <p>Cell surface nucleotide concentrations are regulated by three families of ectonucleotidases in mammalian tissues: Ecto-nucleotide pyrophosphatase/phosphodiesterases (E-NPPs: ATP &#x2192; AMP), alkaline phosphatases (APs: ATP &#x2192; AMP &#x2192; AMP &#x2192; adenosine) and ecto-nucleoside triphosphate diphosphohydrolases (E-NTPDases: ATP &#x2192; AMP &#x2192; AMP) [<xref ref-type="bibr" rid="CR15">15</xref>]. This review describes the importance of regulating extracellular nucleotide concentrations for airway homeostasis and the impact of chronic lung diseases on E-NTPDases. Few studies have addressed the activity or expression of airway E-NTPDases. In this review, the available information is complemented by original data.</p>
    </sec>
    <sec id="Sec2">
      <title>Nucleotide-mediated bacterial clearance</title>
      <p>The importance of purine signaling in the airways is well illustrated in nucleotide-mediated mucociliary clearance (MCC), which constitutes the first line of defense against bacterial infection [<xref ref-type="bibr" rid="CR16">16</xref>]. Mucosal epithelial surfaces are protected by an airway surface liquid (ASL) layer containing a thin mucin sheath kept above the cilia by a periciliary liquid (PCL) layer (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Inhaled bacteria adhere to the mucin and are continuously displaced upward by coordinated cilia beating activity [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Comparative analysis of the bioelectric properties of airway epithelia from normal donors and CF patients revealed that PCL height is regulated by a delicate balance between the activities of the epithelial sodium channel (ENAC) and the cystic fibrosis transmembrane regulator (CFTR) [<xref ref-type="bibr" rid="CR19">19</xref>]. Cystic fibrosis is characterized by mutations in the gene encoding CFTR [<xref ref-type="bibr" rid="CR16">16</xref>]. The lack of ion secretion through CFTR is associated with Na<sup>+</sup> hyperabsorption by ENAC and water influx, resulting in the depletion of the PCL layer essential for cilia beating activity. The cilia become collapsed under a thick layer of mucus filled with bacteria and leukocytes, leading to severe inflammatory responses and progressive loss of lung function.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Impact of chronic obstructive lung diseases on mucociliary clearance. The polarized epithelium is composed of columnar (ciliated or mucin-secreting) cells facing the lumen and basal cells facing the serosal compartment. Bacterial clearance in healthy lungs is maintained by coordinated cilia beating activity within the PCL layer, moving upward the overlying mucus and pathogens. In chronic obstructive lung diseases, cilia are collapsed under a thick layer of mucus containing bacteria and leukocytes.</p></caption><graphic position="anchor" xlink:href="11302_2006_Article_9001_Fig1" id="MO1"/></fig></p>
      <p>Extracellular nucleotides and nucleosides regulate CFTR and ENAC [<xref ref-type="bibr" rid="CR20">20</xref>]. The basal activity of CFTR is maintained by adenosine (A<sub>2B</sub>) receptors, which induce G protein-coupled adenylate cyclase, followed by cAMP-dependent activation of type II protein kinase A [<xref ref-type="bibr" rid="CR5">5</xref>]. In contrast, ATP stimulates Cl<sup>&#x2212;</sup> secretion through Ca<sup>2+</sup>-activated Cl<sup>&#x2212;</sup> channels. This signaling pathway involves P2Y<sub>2</sub> receptors, leading to G protein-coupled phospholipase C activation and cytosolic Ca<sup>2+</sup> mobilization. Water efflux is also stimulated by P2Y<sub>2</sub> receptor-mediated inhibition of Na<sup>+</sup> absorption by ENAC using Ca<sup>2+</sup>-dependent signaling pathways [<xref ref-type="bibr" rid="CR21">21</xref>]. Members of the P2X receptor family also support luminal Cl<sup>&#x2212;</sup>/water efflux in human airway epithelia, as demonstrated in primary cultures and cell lines (Beas2B, 16HBE14o<sup>&#x2212;</sup>, Calu-3, (&#x3A3;CFTE-29o<sup>&#x2212;</sup>) by Ussing chamber and patch-clamp experiments [<xref ref-type="bibr" rid="CR22">22</xref>]. The receptors identified in airway epithelia by RT-PCR were P2X<sub>2</sub>, P2X<sub>4</sub> and P2X<sub>5</sub>. These non-selective cation channels allow Ca<sup>2+</sup> influx, which then stimulates Ca<sup>2+</sup>-activated Cl<sup>&#x2212;</sup> channels. Interestingly, P2X<sub>7</sub> receptors are only detected in CF airway epithelia, primarily in nasal polyps [<xref ref-type="bibr" rid="CR22">22</xref>]. Because they are known to induce apoptosis in response to high ATP concentrations [<xref ref-type="bibr" rid="CR23">23</xref>], P2X<sub>7</sub> receptors may contribute to disease-associated epithelial damage.</p>
      <p>The central role of ASL nucleotides for MCC was further substantiated by the observation that P2Y<sub>2</sub> receptor activation constitutes the most potent stimulus for cilia beating activity [<xref ref-type="bibr" rid="CR24">24</xref>&#x2013;<xref ref-type="bibr" rid="CR26">26</xref>] and mucin secretion [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. In cultured CF airway epithelia, P2Y<sub>2</sub> receptor activation restores normal PCL height and rotational mucus transport [<xref ref-type="bibr" rid="CR29">29</xref>]. Based on these findings, aerosolized nucleotides were proposed for the treatment of chronic obstructive lung diseases [<xref ref-type="bibr" rid="CR16">16</xref>]. However, clinical studies showed that patients with asthma or chronic obstructive pulmonary disease exposed to aerosolized metabolites of ATP (AMP and adenosine) experience coughing and bronchoconstriction [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Furthermore, aerosolized ATP (not adenosine) induced similar reactions from healthy subjects [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. In developing nucleotide-mediated MCC therapies, the equally potent P2Y<sub>2</sub> receptor agonist, UTP, was evaluated [<xref ref-type="bibr" rid="CR6">6</xref>]. Airway clearance in sheep, measured with nebulized technetium-labeled albumin, was transiently increased by UTP [<xref ref-type="bibr" rid="CR34">34</xref>]. Aerosolized UTP also improved MCC in patients with mild chronic bronchitis [<xref ref-type="bibr" rid="CR35">35</xref>], CF [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>] and primary ciliary dyskinesia [<xref ref-type="bibr" rid="CR38">38</xref>].</p>
      <p>A major obstacle to the treatment of chronic lung diseases with aerosolized UTP is the rapid disappearance of therapeutic concentrations (0.1 mM) from the ASL layer (&lt;5 min) [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Incidentally, the metabolically stable UTP analogs INS365 (diquafosol) and INS37217 (denufosol) developed by Inspire Pharmaceuticals Inc. [<xref ref-type="bibr" rid="CR39">39</xref>] were reported to improve cough induced-sputum clearance in CF patients [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. However, long-term treatments with these drugs may require dose optimization to minimize P2Y<sub>2</sub> receptor desensitization [<xref ref-type="bibr" rid="CR42">42</xref>].</p>
    </sec>
    <sec id="Sec3">
      <title>P2 receptors and airway inflammation</title>
      <p><italic>In vivo</italic> studies conducted on the injurious effects of mechanical ventilation demonstrated that endogenous ATP may reach ASL concentrations sufficiently high to trigger inflammatory responses and lung damage in the absence of infection [<xref ref-type="bibr" rid="CR43">43</xref>]. The bronchoalveolar lavage fluid of rats subjected to positive-pressure mechanical ventilation contains significantly higher protein, ATP and cytokine (IL-6, TNF&#x3B1;) levels than control animals. Instillation of an equivalent ATP concentration increased lung fluid volume, supporting the existence of P2 and/or P1 receptor-mediated lung edema [<xref ref-type="bibr" rid="CR43">43</xref>]. Analysis of bronchoalveolar lavage fluid nucleotide content by etheno-derivatization revealed an increase in AMP + adenosine/ADP + ATP ratio [<xref ref-type="bibr" rid="CR44">44</xref>], suggesting that mechanical ventilation up-regulates airway ectonucleotidases. Real-time PCR on total lung tissue indicated that mechanical ventilation increases A<sub>2B</sub>, but decreases P2X<sub>7</sub>, receptor expression. Rats subjected to both mechanical ventilation and positive end-expiratory pressure exhibited normal bronchoalveolar lavage composition and receptor expression. These findings suggest that patients subjected to positive end-expiratory pressure during large-volume ventilation may avoid ATP-mediated lung injuries. On the other hand, the fact that adenosine levels and A<sub>2B</sub> receptor expression were raised, whereas ATP levels and P2X<sub>7</sub> receptor expression were decreased, by mechanical ventilation supports a dynamic role for ectonucleotidases in the regulation of purine signaling in the airways.</p>
      <p>The role of P2 receptors in innate defense against bacterial infection was investigated using mice deficient in P2Y<sub>1</sub>, P2Y<sub>2</sub> or both receptors [<xref ref-type="bibr" rid="CR45">45</xref>]. All these mice exhibited lower survival and lower cytokine levels in lung homogenates than wild-type animals measured 24 h after intranasal instillation of <italic>P. aeruginosa</italic>. These results suggest a protective role for ATP-induced inflammation [<xref ref-type="bibr" rid="CR45">45</xref>]. In human airways, P2Y<sub>2</sub> receptor activation amplified inflammatory responses to bacterial infection. Primary cultures of bronchial epithelial cells exposed to UTP and sputum from CF patients exhibited an eight-fold increase in IL-8 secretion, compared to two-fold with UTP alone [<xref ref-type="bibr" rid="CR46">46</xref>]. Furthermore, P2X<sub>7</sub> receptors are known to support several processes relevant to inflammation, including LPS neutralization [<xref ref-type="bibr" rid="CR47">47</xref>], pathogen killing, nitric oxide production [<xref ref-type="bibr" rid="CR1">1</xref>] and cytokine release from mast cells, leukocytes, dendritic cells and neurons [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. In human blood, LPS-induced IL-1&#x3B2; release is increased 5-fold by P2X<sub>7</sub> receptor activation [<xref ref-type="bibr" rid="CR48">48</xref>]. Altogether, these studies entail that P2 receptor activation may not only induce innate immunity but also amplify pathogen-induced inflammatory responses in chronic infectious lung diseases.</p>
    </sec>
    <sec id="Sec4">
      <title>Too much of a good thing..</title>
      <p>Excessive inflammatory response to recurrent bacterial infection is a major component in the pathogenesis of chronic lung diseases, irreversibly damaging the airways and leading to bronchiectasis and respiratory failure [<xref ref-type="bibr" rid="CR49">49</xref>&#x2013;<xref ref-type="bibr" rid="CR51">51</xref>]. With respect to purine signaling, nucleotide-mediated cell communications may be overwhelmed by massive ATP release from cell lysis of bacteria and damaged epithelia, as well as stimulated leukocytes and epithelia [<xref ref-type="bibr" rid="CR6">6</xref>]. The sensitivity of certain P2 receptors (P2Y<sub>2</sub> [<xref ref-type="bibr" rid="CR42">42</xref>], P2X<sub>1</sub> and P2X<sub>3</sub> [<xref ref-type="bibr" rid="CR52">52</xref>]) to agonist-induced desensitization may reduce the efficiency of nucleotide-mediated MCC [<xref ref-type="bibr" rid="CR53">53</xref>]. On the other hand, chronically elevated ATP may recruit signaling pathways normally dormant in healthy lungs. For instance, P2X<sub>7</sub> receptor activation only induces cytokine release and cell death in response to high ATP concentrations encountered in damaged tissues [<xref ref-type="bibr" rid="CR23">23</xref>]. On astrocytes, LPS-induced TNF&#x3B1; secretion is increased by P2Y receptor activation at low micromolar ATP, but reduced by P2X<sub>7</sub> receptor activation at high ATP concentrations [<xref ref-type="bibr" rid="CR54">54</xref>]. The authors propose a beneficial effect for the potentiation of TNF&#x3B1; secretion by P2Y receptors during mild or acute inflammation and a protective role for P2X<sub>7</sub> receptors in damaged tissues or chronic infectious diseases. These studies suggest that P2X<sub>7</sub> receptor-mediated responses may be tissue-specific and/or influenced by bacterial infections. In the respiratory system, P2Y<sub>2</sub> receptors are expressed throughout airway epithelia [<xref ref-type="bibr" rid="CR39">39</xref>] while P2X<sub>7</sub> receptors have only been reported in nasal polyps of CF patients [<xref ref-type="bibr" rid="CR22">22</xref>]. The impact of P2X and P2Y receptor activation on inflammatory responses mediated by airway epithelia under normal and pathological conditions remains to be investigated.</p>
    </sec>
    <sec id="Sec5">
      <title>E-NTPDases regulate airway ATP</title>
      <p>Several studies demonstrate the presence of ectonucleotidase activities on human airway epithelia [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR55">55</xref>&#x2013;<xref ref-type="bibr" rid="CR58">58</xref>]. Time-course experiments conducted on polarized primary cultures of human bronchial epithelial cells showed that mucosal ATP is dephosphorylated into ADP, AMP and adenosine (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>). Experiments repeated with nasal, bronchial and bronchiolar epithelial cultures indicated that ATP metabolism accelerates toward the alveolar region (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>). Such gradient distribution was also reported for non-specific alkaline phosphatase (NS AP) in human airways [<xref ref-type="bibr" rid="CR9">9</xref>], an ectonucleotidase capable of sequentially dephosphorylating ATP to adenosine [<xref ref-type="bibr" rid="CR59">59</xref>]. However, complete inhibition of NS AP with 10 mM levamisole [<xref ref-type="bibr" rid="CR9">9</xref>] only reduced by 25% total ectoATPase activities [<xref ref-type="bibr" rid="CR10">10</xref>]. Other ATP-regulating ectonucleotidases were identified in mammalian tissues as members of the ENTPDase family [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. They catalyze the hydrolysis of &#x3B3;- and/or &#x3B2;-phosphate residues, resulting in the formation of nucleoside monophosphates. Their activities are Ca<sup>2+</sup> and Mg<sup>2+</sup>-dependent and insensitive to inhibitors of P-, F- and V-type ATPases or APs [<xref ref-type="bibr" rid="CR61">61</xref>]. Four E-NTPDases are localized to cell surfaces: NTPDase 1, 2, 3 and 8. Functional studies showed that NTPDase 1 [<xref ref-type="bibr" rid="CR62">62</xref>] and NTPDase 3 [<xref ref-type="bibr" rid="CR63">63</xref>] are inhibited by azide, whereas NTPDase 2 [<xref ref-type="bibr" rid="CR64">64</xref>] and NTPDase 8 [<xref ref-type="bibr" rid="CR65">65</xref>] are insensitive. The mRNA expression of NTPDase 1, 2 and 3 in human airways was reported in total lung RNA [<xref ref-type="bibr" rid="CR66">66</xref>] and cultured bronchial epithelial cells [<xref ref-type="bibr" rid="CR67">67</xref>]. We now provide evidence that NTPDase 1 and NTPDase 3 are both expressed throughout human airways by real-time PCR on freshly excised epithelial cells (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). Their expression distribution followed surface ectoATPase activities (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>), exhibiting higher mRNA levels in smaller airways (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). The fact that 20 mM azide reduced total ectoATPase activities by 45% on human bronchial epithelial cells [<xref ref-type="bibr" rid="CR67">67</xref>] suggests that the high affinity (K<sub>m</sub> &lt; 15 &#xB5;M) [<xref ref-type="bibr" rid="CR68">68</xref>] NTPDases 1 and/or 3 play major roles in the regulation of physiological ASL nucleotide concentrations.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Ectonucleotidases regulate nucleotide concentrations on airway epithelial surfaces. <bold>a</bold> Polarized primary cultures of human bronchial epithelial cells were assayed with 100 &#xB5;M ATP added to the mucosal surface, as we previously described [<xref ref-type="bibr" rid="CR10">10</xref>]. Buffer sample analysis by high-pressure liquid chromatography (10) shows that exogenous ATP (&#x2022;) is dephosphorylated into ADP (&#x25AA;), AMP (&#x2246;) and adenosine (&#x25CB;). <bold>b</bold> Similar experiments repeated on primary cultures of human nasal, bronchial and bronchiolar epithelial cells show that the elimination rate of ATP increases toward alveoli (<italic>N</italic> = 3, *, <italic>P</italic> &lt; 0.05; Mann-Whitney test).</p></caption><graphic position="anchor" xlink:href="11302_2006_Article_9001_Fig2" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Expression level of NTPDase 1 and NTPDase 3 along human airways. Total RNA from excised epithelia was analyzed by real-time PCR using SYBR green assays and normalized to the expression level of the house-keeping gene, 18S, as we previously described [<xref ref-type="bibr" rid="CR89">89</xref>]. The mRNA level of E-NTPDase 1 (&#x25A1;) and NTPDase 3 (&#x25AA;) increases toward alveoli (<italic>N</italic> = 4, *, <italic>P</italic> &lt; 0.05; Mann-Whitney test).</p></caption><graphic position="anchor" xlink:href="11302_2006_Article_9001_Fig3" id="MO3"/></fig></p>
      <p>The physiological importance of azide-sensitive E-NTPDases for nucleotide-mediated MCC was recently established using an <italic>in vitro</italic> model of rhythmic breathing. Airway epithelia are continuously subjected to mechanical stress generated by breathing, coughing or chest movement. Since mechanical stress induces epithelial ATP release [<xref ref-type="bibr" rid="CR6">6</xref>], static culture conditions may underestimate the lungs capacity to regulate MCC <italic>in vivo</italic>. Rhythmic pressure changes mimicking normal tidal breathing were reproduced <italic>in vitro</italic> by a system applying cyclic compressive stress (CCS) to the mucosal surface of primary bronchial epithelial cultures [<xref ref-type="bibr" rid="CR69">69</xref>]. Whereas CF cultures under static conditions exhibit a depleted PCL layer and mucostasis, CCS mimicking normal tidal breathing (20 cmH<sub>2</sub>O; 15 cycles/min) restored normal PCL height and mucus transport through ATP release and P2Y<sub>2</sub> receptor activation. These results also suggest that purine signaling may provide an explanation for the beneficial effects of oscillatory therapeutic devices clinically used to stimulate sputum clearance [<xref ref-type="bibr" rid="CR70">70</xref>].</p>
      <p>Cyclic compressive stress also enhances MCC through a reduction in ASL nucleotide metabolism. We recently demonstrated that CCS decreases the rate of ATP hydrolysis on the mucosal surface of normal and CF bronchial epithelial cultures [<xref ref-type="bibr" rid="CR67">67</xref>]. More importantly, CCS restored normal ectoATPase activities on CF epithelial surfaces. The inhibitory effect of CCS on ATP metabolism was abrogated by 20 mM azide, indicating that E-NTPDase 1 and/or E-NTPDase 3 are key components in the regulation P2 receptormediated MCC. Perhaps the ability of CF airway epithelia to provide adequate nucleotide-mediated MCC under conditions mimicking normal breathing may contribute to the relatively healthy state of young patients before the establishment of chronic infection [<xref ref-type="bibr" rid="CR71">71</xref>].</p>
    </sec>
    <sec id="Sec6">
      <title>Chronic lung diseases shorten the signals</title>
      <p>Recent studies demonstrate that chronic lung diseases accelerate all metabolic steps supporting the mucosal conversion of ATP to adenosine [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. We identified the ectonucleotidases involved using primary bronchial epithelial cultures from healthy donors and patients with primary ciliary dyskinesia, CF or &#x3B1;1-antitrypsin deficiency. All airway diseases were characterized by a two- to four-fold increase in the elimination rate of ATP on the mucosal surface, without significant effect on the serosal surface (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). Selective inhibitors of NS AP (10 mM levamisole), NTPDase 1 and NTPDase 3 (20 mM azide) partially restored normal activity levels. However, the lower substrate affinities of airway NS AP (36 &#xB5;M and 717 &#xB5;M) [<xref ref-type="bibr" rid="CR9">9</xref>] suggest that NTPDase 1 and/or NTPDase 3 are responsible for the accelerated clearance of P2 receptor agonists in diseased airways.
<fig id="Fig4"><label>Fig. 4</label><caption><p>Chronic lung diseases enhance azide-sensitive E-NTPDases. Primary bronchial epithelial cultures from healthy donors (<italic>N</italic>) and patients diagnosed with primary ciliary dyskinesia (PCD), CF or &#x3B1;1-antitrypsin deficiency (&#x3B1; AT) were assayed with bilateral 1 mM ATP in the absence (&#x25AA;) or presence (&#x25A1;) of 20 mM azide, as we previously described [<xref ref-type="bibr" rid="CR10">10</xref>]. Analysis of buffer samples by high-pressure liquid chromatography showed that azide-sensitive E-NTPDases are concentrated on the mucosal surface under normal and pathological conditions (<italic>N</italic> = 4, *, <italic>P</italic> &lt; 0.05; Mann-Whitney test).</p></caption><graphic position="anchor" xlink:href="11302_2006_Article_9001_Fig4" id="MO4"/></fig></p>
      <p><italic>Pseudomonas aeruginosa</italic> is among the most frequently isolated pathogens from the airways of patients with gram-negative infections [<xref ref-type="bibr" rid="CR51">51</xref>]. In patients with damaged airways from mechanical ventilation, trauma or viral infection, airway colonization by <italic>P. aeruginosa</italic> is often followed by pneumonia, sepsis and death. Much of the airway inflammation induced by these organisms is caused by released bacterial products adhering to the epithelial surface, such as LPS. The contribution of bacterial infection to the deregulation of E-NTPDase activities in lung diseases was examined using <italic>P. aeruginosa</italic> LPS. Primary cultures of human bronchial epithelial cells exposed 24 h on the mucosal surface to an optimum LPS concentration (100 ng/ml) [<xref ref-type="bibr" rid="CR73">73</xref>] exhibited a biphasic response over time (Fig. <xref rid="Fig5" ref-type="fig">5A</xref>). Azide-sensitive E-NTPDases were transiently reduced over 8 h, without affecting mRNA expression. In contrast, prolonged exposures (24 h) raised the activities two-fold above control levels and increased NTPDase 1 and NTPDase 3 expression by 4 and 10-fold (Fig. <xref rid="Fig5" ref-type="fig">5B</xref>). These opposite effects suggest that two regulatory mechanisms may be involved in the acute and chronic effects of LPS on airway E-NTPDases.
<fig id="Fig5"><label>Fig. 5</label><caption><p>Impact of <italic>P. aeruginisa</italic> LPS on NTPDase 1 and NTPDase 3. <bold>A</bold> The mucosal surface of primary bronchial epithelial cultures were exposed 0, 1, 8 or 24 h to 100 ng/ml LPS, then assayed for surface activity by high-pressure liquid chromatography, as we previously described [<xref ref-type="bibr" rid="CR10">10</xref>]. The activities of azidesensitive mucosal E-NTPDases measured with 0.03 mM ATP were transiently reduced by LPS. <bold>B</bold> Quantification of their mRNA expression by real-time PCR using the house-keeping gene 18S, as we previously described (89). LPS induced a delayed increase in the expression level of both E-NTPDases (<italic>N</italic> = 5, *, <italic>P</italic> &lt; 0.05; Mann-Whitney test).</p></caption><graphic position="anchor" xlink:href="11302_2006_Article_9001_Fig5" id="MO5"/></fig></p>
      <p>Oxidative stress is one of the major causes of epithelial injury in chronic lung diseases [<xref ref-type="bibr" rid="CR74">74</xref>]. Reactive oxygen and nitrogen species released from airway epithelia or activated leukocytes damage cell membranes by peroxidation of lipids, amino acids and carbohydrates. <italic>P aeruginosa</italic> LPS was reported to induce their release from airway epithelia [<xref ref-type="bibr" rid="CR75">75</xref>]. Incidentally, intrahepatic cholestasis induced by intraperitoneal injection of LPS reduced total liver NTPDase 1 activity within 2 h [<xref ref-type="bibr" rid="CR76">76</xref>]. In a rat model of glomerulopathy, short-term exposure (1 h) to LPS inactivated endothelial NTPDase 1, which was prevented by pre-treatment with the anti-oxidant superoxide dismutase [<xref ref-type="bibr" rid="CR77">77</xref>]. Oxidative stress induced by membrane depolarization [<xref ref-type="bibr" rid="CR78">78</xref>] or ischemia/ reperfusion [<xref ref-type="bibr" rid="CR79">79</xref>] also inhibited endothelial NTPDase 1. Furthermore, short exposures (4 h) to the pro-inflammatory cytokine, TNF&#x3B1;, inhibited endothelial NTPDase 1, which was mimicked by hydrogen peroxide but prevented by superoxide dismutase [<xref ref-type="bibr" rid="CR80">80</xref>]. Altogether, these studies suggest that oxidative stress may be responsible for the early and transient reduction in azide-sensitive E-NTPDase activities detected in LPS-treated airway epithelia. Since the mRNA expression of E-NTPDases is unaffected by acute oxidative stress [<xref ref-type="bibr" rid="CR80">80</xref>] or LPS (Fig. <xref rid="Fig5" ref-type="fig">5B</xref>), and the inactivation of NTPDase 1 by ischemia/reperfusion was prevented by inhibitors of lipid peroxidation [<xref ref-type="bibr" rid="CR79">79</xref>], the early loss of surface activity may involve local peroxidation of membrane lipids.</p>
      <p>The long-term effects of LPS on the azide-sensitive E-NTPDases have not been documented in mammalian tissues. On the other hand, a 24 h exposure to endotoxin stimulated NTPDase 2 on astrocytes [<xref ref-type="bibr" rid="CR81">81</xref>], as well as NS AP on endothelial, mesengial [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>] and bronchial epithelial [<xref ref-type="bibr" rid="CR73">73</xref>] cells. Additionally, the mRNA expression of NTPDase 1 in rat forebrain was up-regulated seven days after transient ischemia [<xref ref-type="bibr" rid="CR84">84</xref>]. <italic>P. aeruginosa</italic> LPS [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR86">86</xref>] is well-known to influence gene expression through the activation of the transcription factors: Nuclear factor-kappa B and activator protein-1 [<xref ref-type="bibr" rid="CR87">87</xref>]. Recent studies have shown that CFTR acts as a pattern recognition molecule for <italic>P. aeruginosa</italic> LPS [<xref ref-type="bibr" rid="CR88">88</xref>]. Endocytosis of the complex triggers translocation of these transcription factors to the nucleus, which initiates innate immunity through the expression of numerous mediators recruiting and activating inflammatory cells. These signaling pathways could be involved in the up-regulation of NTPDase 1 and NTPDase 3 expression resulting from long-term exposures to <italic>P. aeruginosa LPS</italic> in human airways.</p>
    </sec>
    <sec id="Sec7">
      <title>Adaptation of purine signaling to airway diseases</title>
      <p>In past decade, the therapeutic potential of aerosolized nucleotides for the treatment of chronic obstructive lung diseases has motivated numerous studies on the importance of purine signaling in the airways. This elaborated cell communication system is involved in major defense mechanisms including bacterial clearance and inflammatory responses to bacterial infection. Each signaling event constitutes a brief &#x2018;on-and-off&#x2019; switch mechanism allowing the target cells to perceive the subsequent signal. Environmental changes are communicated to target cells in the form of released ATP, which binds surface receptors and triggers an appropriate response. The efficiency of this communication system depends on the cells capacity to rapidly eliminate these local bursts in extracellular ATP concentrations to prevent receptor desensitization. This review establishes the pivotal role of E-NTPDases in the regulation of airway defenses mediated by purine signaling, namely bacterial clearance (Fig. <xref rid="Fig6" ref-type="fig">6</xref>). Cyclic compressive stress, mimicking normal breathing or clinical oscillatory devices, stimulates P2 receptormediated MCC through ATP release and reduced azide-sensitive E-NTPDase activities. We also presented original data indicating that NTPDase 1 and 3 activities and expressions are up-regulated in chronic lung diseases by inflammatory mediators, including endotoxin. Interestingly, <italic>P. aeruginosa</italic> LPS generated a biphasic modulation of airway E-NTPDases which may reconcile previous conflicting reports based on exposure duration. Acute LPS exposures reduced ENTPDase activities, as observed during CCS, most likely to clear a pathogen through P2 receptor-mediated MCC. The signaling pathways activated by <italic>P. aeruginosa</italic> LPS and the lack of concomitant reduction in ENTPDase mRNA levels support a local inhibitory mechanism that may involve oxidative stress-mediated membrane damage. On the other hand, prolonged endotoxin exposures mimicked the impact of chronic lung diseases on NTPDases 1 and 3, characterized by an up-regulation of both activities and mRNA expression. In chronically infected lungs, an increase in E-NTPDase activities may represent an attempt to prevent lung damage, excessive inflammation and P2 receptor desensitization by chronically elevated ATP concentrations.
<fig id="Fig6"><label>Fig. 6</label><caption><p>Purine signaling and nucleotide salvage pathways on human airway epithelia. In normal lungs, basal adenosine levels maintain adequate PCL height for mucus transport through A<sub>2B</sub> receptor-mediated CFTR activity. Mechanical stimulation of the epithelial surface by an irritant, a pathogen, mechanical ventilation or cyclic compressive stress induces ATP release and elevates ASL concentrations above activation threshold level for P2Y<sub>2</sub> receptor activation. This autocrine signal transiently enhances basal MCC through cilia beating, mucin secretion and ion/water efflux into the lumen. The signal is rapidly terminated by NTPDase 1 and/or NTPDase 3 dephosphorylating excess ATP to AMP. Ecto 5&#x2032;-nucleotidase (ecto 5&#x2032;-NT; CD73) produces ASL adenosine from the resulting AMP, and excess adenosine is transported back to the cytosol. Chronic lung diseases burdened by considerable tissue damage recruits additional receptors (P2X<sub>4, 5, 7</sub>) responding to higher ATP cocnentrations.</p></caption><graphic position="anchor" xlink:href="11302_2006_Article_9001_Fig6" id="MO6"/></fig></p>
      <p>The information provided in this review also exposes the complexity of the signaling interactions taking place between different classes of mediators, including bacterial products, cytokines and extracellular nucleotides, as combinations of mediators may induce different responses than when tested individually. Furthermore, communication networks in the airways may evolve with time during the establishment of a chronic infection, as new target cells (bacteria, leukocytes, lymphocytes) agglomerate on either side of the epithelial barrier. It is proposed that nucleotide-mediated airway functions defined in normal tissues or aseptic culture conditions may require reassessment under conditions mimicking chronic lung diseases before their therapeutic potential may be clearly established.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgment</title>
      <p>The human nasal and bronchial epithelial cells were provided by the Tissue Culture Core of the Cystic Fibrosis Center (UNC-CH), directed by Dr Scott H. Randell. This work was supported by the Cystic Fibrosis Foundation (Picher 02I0 and Picher 05G0).</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pelleg</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Schulman</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Adenosine 5&#x2019;-triphosphate axis in obstructive airway diseases</article-title>
          <source>Am J Ther</source>
          <year>2002</year>
          <volume>9</volume>
          <fpage>454</fpage>
          <lpage>464</lpage>
          <pub-id pub-id-type="doi">10.1097/00045391-200209000-00014</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Pelleg A, Schulman E (2002) Adenosine 5&#x2019;-triphosphate axis in obstructive airway diseases. Am J Ther 9:454&#x2013;64 <pub-id pub-id-type="pmid">12237739</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Knight</surname>
              <given-names>GE.</given-names>
            </name>
          </person-group>
          <article-title>Cellular distribution and functions of P2 receptor subtypes in different systems</article-title>
          <source>Int Rev Cytol</source>
          <year>2004</year>
          <volume>240</volume>
          <fpage>31</fpage>
          <lpage>304</lpage>
          <pub-id pub-id-type="doi">10.1016/S0074-7696(04)40002-3</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G, Knight GE (2004) Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240:31&#x2013;304 <pub-id pub-id-type="pmid">15548415</pub-id></citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dubyak</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Purinergic signaling at immunological synapses</article-title>
          <source>J Auton Nerv Syst</source>
          <year>2000</year>
          <volume>81</volume>
          <fpage>64</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="doi">10.1016/S0165-1838(00)00155-7</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Dubyak GR (2000) Purinergic signaling at immunological synapses. J Auton Nerv Syst 81:64&#x2013;8 <pub-id pub-id-type="pmid">10869702</pub-id></citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Homolya</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Steinberg</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Cell to cell communication in response to mechanical stress via bilateral release of ATP and UTP in polarized epithelia</article-title>
          <source>J Cell Biol</source>
          <year>2000</year>
          <volume>150</volume>
          <fpage>1349</fpage>
          <lpage>1360</lpage>
          <pub-id pub-id-type="doi">10.1083/jcb.150.6.1349</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Homolya L, Steinberg TH, Boucher RC (2000). Cell to cell communication in response to mechanical stress via bilateral release of ATP and UTP in polarized epithelia. J Cell Biol 150:1349&#x2013;60 <pub-id pub-id-type="pmid">10995440</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lazarowski</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Tarran</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2001</year>
          <volume>98</volume>
          <fpage>14120</fpage>
          <lpage>14125</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.241318498</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Huang P, Lazarowski ER, Tarran R et al (2001) Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells. Proc Natl Acad Sci USA 98:14120&#x2013;5 <pub-id pub-id-type="pmid">11707576</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lazarowski</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Harden</surname>
              <given-names>TK</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules</article-title>
          <source>Mol Pharmacol</source>
          <year>2003</year>
          <volume>64</volume>
          <fpage>785</fpage>
          <lpage>795</lpage>
          <pub-id pub-id-type="doi">10.1124/mol.64.4.785</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Lazarowski ER, Boucher RC, Harden TK (2003) Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol 64:785&#x2013;95 <pub-id pub-id-type="pmid">14500734</pub-id></citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Gabriel</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Fuller</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Calcium-activated Cl-conductance in the airway epithelium</article-title>
          <source>Current Topics in Membranes</source>
          <year>2002</year>
          <publisher-loc>San Diego</publisher-loc>
          <publisher-name>Elsevier Science</publisher-name>
          <fpage>193</fpage>
          <lpage>207</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gabriel SE (2002) Calcium-activated Cl-conductance in the airway epithelium. In: Fuller CM (ed) Current topics in membranes. San Diego, Elsevier Science, pp 193&#x2013;207 </citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boeynaems</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Communi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>NS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Overview of the P2 receptors</article-title>
          <source>Semin Thromb Hemost</source>
          <year>2005</year>
          <volume>31</volume>
          <fpage>139</fpage>
          <lpage>149</lpage>
          <pub-id pub-id-type="doi">10.1055/s-2005-869519</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Boeynaems JM, Communi D, Gonzalez NS et al (2005) Overview of the P2 receptors. Semin Thromb Hemost 31:139&#x2013;49 <pub-id pub-id-type="pmid">15852217</pub-id></citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Picher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Burch</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Hirsh</surname>
              <given-names>AJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ecto 5&#x2019;-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways</article-title>
          <source>J Biol Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>13468</fpage>
          <lpage>13479</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M300569200</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Picher M, Burch LH, Hirsh AJ et al (2003) Ecto 5&#x2019;-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J Biol Chem 278:13468&#x2013;79 <pub-id pub-id-type="pmid">12560324</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Picher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Burch</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Metabolism of P2 receptor agonists in human airways: Implications for mucociliary clearance and cystic fibrosis</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>20234</fpage>
          <lpage>20241</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M400305200</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Picher M, Burch LH, Boucher RC (2004) Metabolism of P2 receptor agonists in human airways: Implications for mucociliary clearance and cystic fibrosis. J Biol Chem 279:20234&#x2013;41 <pub-id pub-id-type="pmid">14993227</pub-id></citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fredholm</surname>
              <given-names>BB</given-names>
            </name>
          </person-group>
          <article-title>Adenosine receptors as targets for drug development</article-title>
          <source>Drug News Perspect</source>
          <year>2003</year>
          <volume>16</volume>
          <fpage>283</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="doi">10.1358/dnp.2003.16.5.829316</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Fredholm BB (2003) Adenosine receptors as targets for drug development. Drug News Perspect 16:283&#x2013;9 <pub-id pub-id-type="pmid">12942159</pub-id></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>New concepts of the pathogenesis of cystic fibrosis lung disease</article-title>
          <source>Eur Respir J</source>
          <year>2004</year>
          <volume>23</volume>
          <fpage>146</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="doi">10.1183/09031936.03.00057003</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Boucher RC (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 23:146&#x2013;58 <pub-id pub-id-type="pmid">14738247</pub-id></citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greenberg</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>cAMP and purinergic P2Y receptors up-regulate and enhance inducible NO synthase mRNA and protein <italic>in vivo</italic></article-title>
          <source>Am J Physiol</source>
          <year>1997</year>
          <volume>273</volume>
          <fpage>L967</fpage>
          <lpage>L979</lpage>
        </citation>
        <citation citation-type="display-unstructured">Greenberg S, Zhao X, Wang J et al (1997) cAMP and purinergic P2Y receptors up-regulate and enhance inducible NO synthase mRNA and protein in vivo. Am J Physiol 273:L967&#x2013;79 <pub-id pub-id-type="pmid">9374723</pub-id></citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sala</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ferrari</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Virgilio</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Alerting and tuning the immune response by extracellular nucleotides</article-title>
          <source>J Leukoc Biol</source>
          <year>2003</year>
          <volume>73</volume>
          <fpage>339</fpage>
          <lpage>343</lpage>
          <pub-id pub-id-type="doi">10.1189/jlb.0802418</pub-id>
        </citation>
        <citation citation-type="display-unstructured">La Sala A, Ferrari D, Di Virgilio F et al (2003) Alerting and tuning the immune response by extracellular nucleotides. J Leukoc Biol 73:339&#x2013;43 <pub-id pub-id-type="pmid">12629147</pub-id></citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmermann</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Ectonucleotidases: Some recent developments and a note on nomenclature</article-title>
          <source>Drug Dev Res</source>
          <year>2001</year>
          <volume>52</volume>
          <fpage>44</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="doi">10.1002/ddr.1097</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Zimmermann H (2001) Ectonucleotidases: Some recent developments and a note on nomenclature. Drug Dev Res 52:44&#x2013;56 </citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>New concepts of the pathogenesis of cystic fibrosis lung disease</article-title>
          <source>Eur Respir J</source>
          <year>2004</year>
          <volume>23</volume>
          <fpage>146</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="doi">10.1183/09031936.03.00057003</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Boucher RC (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 23:146&#x2013;58 <pub-id pub-id-type="pmid">14738247</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tarran</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Thin-film measurements of airway surface liquid volume/composition and mucus transport rates <italic>in vitro</italic></article-title>
          <source>Methods Mol Med</source>
          <year>2002</year>
          <volume>70</volume>
          <fpage>479</fpage>
          <lpage>492</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tarran R, Boucher RC (2002) Thin-film measurements of airway surface liquid volume/composition and mucus transport rates in vitro. Methods Mol Med 70:479&#x2013;92 <pub-id pub-id-type="pmid">11917544</pub-id></citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roomans</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Kozlova</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Nilsson</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Measurements of airway surface liquid height and mucus transport by fluorescence microscopy, and of ion composition by X-ray microanalysis</article-title>
          <source>J Cyst Fibros</source>
          <year>2004</year>
          <volume>3</volume>
          <issue>Suppl 2</issue>
          <fpage>135</fpage>
          <lpage>139</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jcf.2004.05.029</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Roomans GM, Kozlova I, Nilsson H et al (2004) Measurements of airway surface liquid height and mucus transport by fluorescence microscopy, and of ion composition by X-ray microanalysis. J Cyst Fibros 3(Suppl 2):135&#x2013;9 <pub-id pub-id-type="pmid">15463946</pub-id></citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tarran</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Regulation of airway surface liquid volume and mucus transport by active ion transport</article-title>
          <source>Proc Am Thorac Soc</source>
          <year>2004</year>
          <volume>1</volume>
          <fpage>42</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="doi">10.1513/pats.2306014</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Tarran R (2004) Regulation of airway surface liquid volume and mucus transport by active ion transport. Proc Am Thorac Soc 1:42&#x2013;6 <pub-id pub-id-type="pmid">16113411</pub-id></citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Gabriel</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Crystal</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Ion channels</article-title>
          <source>The Lung</source>
          <year>1997</year>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Lippincott-Raven</publisher-name>
          <fpage>205</fpage>
          <lpage>318</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gabriel SE, Boucher RC (1997) Ion channels. In: Crystal RG, West JB (eds) The lung. Philadelphia, Lippincott-Raven, pp 205&#x2013;318 </citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mall</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wissner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gonska</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Inhibition of amiloride-sensitive epithelial Na<sup>+</sup> absorption by extracellular nucleotides in human normal and cystic fibrosis airways</article-title>
          <source>Am J Respir Cell Mol Biol</source>
          <year>2000</year>
          <volume>23</volume>
          <fpage>755</fpage>
          <lpage>761</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mall M, Wissner A, Gonska T et al (2000) Inhibition of amiloride-sensitive epithelial Na+ absorption by extracellular nucleotides in human normal and cystic fibrosis airways. Am J Respir Cell Mol Biol 23:755&#x2013;61 <pub-id pub-id-type="pmid">11104728</pub-id></citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Schwiebert</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>JJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epithelial P2X purinergic receptor channel expression and function</article-title>
          <source>J Clin Invest</source>
          <year>1999</year>
          <volume>104</volume>
          <fpage>875</fpage>
          <lpage>884</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI7270</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Taylor AL, Schwiebert LM, Smith JJ et al (1999) Epithelial P2X purinergic receptor channel expression and function. J Clin Invest 104:875&#x2013;84 <pub-id pub-id-type="pmid">10510328</pub-id></citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adinolfi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pizzirani</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Idzko</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2X<sub>7</sub> receptor: Death or life?</article-title>
          <source>Purin Signal</source>
          <year>2005</year>
          <volume>1</volume>
          <fpage>219</fpage>
          <lpage>227</lpage>
          <pub-id pub-id-type="doi">10.1007/s11302-005-6322-x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Adinolfi E, Pizzirani C, Idzko M et al (2005) P2X7 receptor: Death or life? Purin Signal 1:219&#x2013;27 </citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Yeates</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>Luminal purinergic regulatory mechanisms of tracheal ciliary beat frequency</article-title>
          <source>Am J Respir Cell Mol Biol</source>
          <year>1992</year>
          <volume>7</volume>
          <fpage>447</fpage>
          <lpage>454</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wong LB, Yeates DB (1992) Luminal purinergic regulatory mechanisms of tracheal ciliary beat frequency. Am J Respir Cell Mol Biol 7:447&#x2013;54 <pub-id pub-id-type="pmid">1389212</pub-id></citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evans</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Sanderson</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Intracellular calcium oscillations regulate ciliary beat frequency of airway epithelial cells</article-title>
          <source>Cell Calcium</source>
          <year>1999</year>
          <volume>26</volume>
          <fpage>103</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="doi">10.1054/ceca.1999.0060</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Evans JH, Sanderson MJ (1999) Intracellular calcium oscillations regulate ciliary beat frequency of airway epithelial cells. Cell Calcium 26:103&#x2013;10 <pub-id pub-id-type="pmid">10598274</pub-id></citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morse</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Smullen</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
          <article-title>Differential effects of UTP, ATP, and adenosine on ciliary activity of human nasal epithelial cells</article-title>
          <source>Am J Physiol</source>
          <year>2001</year>
          <volume>280</volume>
          <fpage>C1485</fpage>
          <lpage>C1497</lpage>
        </citation>
        <citation citation-type="display-unstructured">Morse DM, Smullen JL, Davis CW (2001) Differential effects of UTP, ATP, and adenosine on ciliary activity of human nasal epithelial cells. Am J Physiol 280:C1485&#x2013;97 </citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davis</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Regulation of mucin secretion in <italic>in vitro</italic> cellular models</article-title>
          <source>Novartis Found Symp</source>
          <year>2002</year>
          <volume>248</volume>
          <fpage>113</fpage>
          <lpage>125</lpage>
          <pub-id pub-id-type="doi">10.1002/0470860790.ch8</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Davis C (2002) Regulation of mucin secretion in in vitro cellular models. Novartis Found Symp 248:113&#x2013;25 <pub-id pub-id-type="pmid">12568491</pub-id></citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conway</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Bartolotta</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Abdullah</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
          <article-title>Regulation of mucin secretion from human bronchial epithelial cells grown in murine hosted xenografts</article-title>
          <source>Am J Physiol</source>
          <year>2003</year>
          <volume>284</volume>
          <fpage>L945</fpage>
          <lpage>L954</lpage>
        </citation>
        <citation citation-type="display-unstructured">Conway JD, Bartolotta T, Abdullah LH, Davis CW (2003) Regulation of mucin secretion from human bronchial epithelial cells grown in murine hosted xenografts. Am J Physiol 284:L945&#x2013;54 </citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tarran</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Grubb</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Parsons</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The CF salt controversy: <italic>In vivo</italic> observations and therapeutic approaches</article-title>
          <source>Mol Cell</source>
          <year>2001</year>
          <volume>8</volume>
          <fpage>149</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="doi">10.1016/S1097-2765(01)00286-6</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Tarran R, Grubb BR, Parsons D et al (2001) The CF salt controversy: In vivo observations and therapeutic approaches. Mol Cell 8:149&#x2013;58 <pub-id pub-id-type="pmid">11511368</pub-id></citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Polosa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rorke</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Holgate</surname>
              <given-names>ST</given-names>
            </name>
          </person-group>
          <article-title>Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease</article-title>
          <source>Thorax</source>
          <year>2002</year>
          <volume>57</volume>
          <fpage>649</fpage>
          <lpage>654</lpage>
          <pub-id pub-id-type="doi">10.1136/thorax.57.7.649</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Polosa R, Rorke S, Holgate ST (2002) Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Thorax 57:649&#x2013;54 <pub-id pub-id-type="pmid">12096211</pub-id></citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berge</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Polosa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kerstjens</surname>
              <given-names>HAM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The role of endogenous and exogenous AMP in asthma and chronic obstructive pulmonary disease</article-title>
          <source>J Allergy Clin Immunol</source>
          <year>2004</year>
          <volume>114</volume>
          <fpage>737</fpage>
          <lpage>746</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jaci.2004.05.071</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Van den Berge M, Polosa R, Kerstjens HAM et al (2004) The role of endogenous and exogenous AMP in asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 114:737&#x2013;46 <pub-id pub-id-type="pmid">15480309</pub-id></citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Basoglu</surname>
              <given-names>OK</given-names>
            </name>
            <name>
              <surname>Pelleg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Essilfie-Quaye</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effects of aerosolized adenosine 5&#x2019;-triphosphate vs adenosine 5&#x2019;-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma</article-title>
          <source>Chest</source>
          <year>2005</year>
          <volume>128</volume>
          <fpage>1905</fpage>
          <lpage>1909</lpage>
          <pub-id pub-id-type="doi">10.1378/chest.128.4.1905</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Basoglu OK, Pelleg A, Essilfie-Quaye S et al (2005) Effects of aerosolized adenosine 5&#x2019;-triphosphate vs adenosine 5&#x2019;-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma. Chest 128:1905&#x2013;9 <pub-id pub-id-type="pmid">16236834</pub-id></citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pellegrino</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Jenouri</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lung mechanics during induced bronchoconstriction</article-title>
          <source>J Appl Physiol</source>
          <year>1996</year>
          <volume>81</volume>
          <fpage>964</fpage>
          <lpage>975</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pellegrino R, Wilson O, Jenouri G et al (1996) Lung mechanics during induced bronchoconstriction. J Appl Physiol 81:964&#x2013;75 <pub-id pub-id-type="pmid">8872669</pub-id></citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sabater</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Mao</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Shaffer</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Aerosolization of P2Y<sub>2</sub>-receptor agonists enhances mucociliary clearance in sheep</article-title>
          <source>J Appl Physiol</source>
          <year>1999</year>
          <volume>87</volume>
          <fpage>2191</fpage>
          <lpage>2196</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sabater JR, Mao YM, Shaffer C et al (1999) Aerosolization of P2Y2-receptor agonists enhances mucociliary clearance in sheep. J Appl Physiol 87:2191&#x2013;6 <pub-id pub-id-type="pmid">10601167</pub-id></citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bennett</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Zeman</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Foy</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of aerosolized uridine 5&#x2019;-triphosphate on mucociliary clearance in mild chronic bronchitis</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>2001</year>
          <volume>164</volume>
          <fpage>302</fpage>
          <lpage>306</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bennett WD, Zeman KL, Foy C et al (2001) Effect of aerosolized uridine 5&#x2019;-triphosphate on mucociliary clearance in mild chronic bronchitis. Am J Respir Crit Care Med 164:302&#x2013;6 <pub-id pub-id-type="pmid">11463605</pub-id></citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bennett</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Olivier</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Zeman</surname>
              <given-names>KL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of uridine 5&#x2019;-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>1996</year>
          <volume>153</volume>
          <fpage>1796</fpage>
          <lpage>1801</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bennett WD, Olivier KN, Zeman KL et al (1996) Effect of uridine 5&#x2019;-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. Am J Respir Crit Care Med 153:1796&#x2013;801 <pub-id pub-id-type="pmid">8665037</pub-id></citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olivier</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Hohneker</surname>
              <given-names>KW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute safety and effects on mucociliary clearance of aerosolized uridine 5&#x2019;-triphosphate +/&#x2212; amiloride in normal human adults</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>1996</year>
          <volume>154</volume>
          <fpage>217</fpage>
          <lpage>223</lpage>
        </citation>
        <citation citation-type="display-unstructured">Olivier KN, Bennett WD, Hohneker KW et al (1996) Acute safety and effects on mucociliary clearance of aerosolized uridine 5&#x2019;triphosphate +/&#x2212; amiloride in normal human adults. Am J Respir Crit Care Med 154:217&#x2013;23 <pub-id pub-id-type="pmid">8680683</pub-id></citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Noone</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Regnis</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of aerosolized uridine-5&#x2019;-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>1999</year>
          <volume>160</volume>
          <fpage>144</fpage>
          <lpage>149</lpage>
        </citation>
        <citation citation-type="display-unstructured">Noone PG, Bennett WD, Regnis JA et al (1999) Effect of aerosolized uridine-5&#x2019;-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia. Am J Respir Crit Care Med 160:144&#x2013;9 <pub-id pub-id-type="pmid">10390392</pub-id></citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yerxa</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Sabater</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>CW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pharmacology of INS37217 [P1-(uridine 5&#x2019;)-P4- (2&#x2019;-deoxycytidine 5&#x2019;) tetraphosphate, tetrasodium salt], a next-generation P2Y<sub>2</sub> receptor agonist for the treatment of cystic fibrosis</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2002</year>
          <volume>302</volume>
          <fpage>871</fpage>
          <lpage>880</lpage>
          <pub-id pub-id-type="doi">10.1124/jpet.102.035485</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Yerxa BR, Sabater JR, Davis CW et al (2002) Pharmacology of INS37217 [P1-(uridine 5&#x2019;)-P4- (2&#x2019;deoxycytidine 5&#x2019;) tetraphosphate, tetrasodium salt], a next-generation P2Y2 receptor agonist for the treatment of cystic fibrosis. J Pharmacol Exp Ther 302:871&#x2013;80 <pub-id pub-id-type="pmid">12183642</pub-id></citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kellerman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mathews</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shaffer</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Inhaled P2Y<sub>2</sub> receptor agonists as a treatment for patients with Cystic Fibrosis lung disease</article-title>
          <source>Adv Drug Deliv Rev</source>
          <year>2002</year>
          <volume>54</volume>
          <fpage>1463</fpage>
          <lpage>1474</lpage>
          <pub-id pub-id-type="doi">10.1016/S0169-409X(02)00154-0</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Kellerman D, Evans R, Mathews D, Shaffer C (2002) Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease. Adv Drug Deliv Rev 54:1463&#x2013;74 <pub-id pub-id-type="pmid">12458155</pub-id></citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deterding</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Retsch-Bogart</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Milgram</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y<sub>2</sub> receptor agonist: Results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis</article-title>
          <source>Pediatr Pulmonol</source>
          <year>2005</year>
          <volume>39</volume>
          <fpage>339</fpage>
          <lpage>348</lpage>
          <pub-id pub-id-type="doi">10.1002/ppul.20192</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Deterding R, Retsch-Bogart G, Milgram L et al (2005) Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: Results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis. Pediatr Pulmonol 39:339&#x2013;48 <pub-id pub-id-type="pmid">15704203</pub-id></citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarke</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Harline</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Otero</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Desensitization of P2Y<sub>2</sub> receptor-activated transepithelial anion secretion</article-title>
          <source>Am J Physiol Cell Physiol</source>
          <year>1999</year>
          <volume>276</volume>
          <fpage>C777</fpage>
          <lpage>C787</lpage>
        </citation>
        <citation citation-type="display-unstructured">Clarke LL, Harline MC, Otero MA et al (1999) Desensitization of P2Y2 receptor-activated transepithelial anion secretion. Am J Physiol Cell Physiol 276:C777&#x2013;87 </citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rich</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Douillet</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Mahler</surname>
              <given-names>SA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine triphosphate is released during injurious mechanical ventilation and contributes to lung edema</article-title>
          <source>J Trauma</source>
          <year>2003</year>
          <volume>55</volume>
          <fpage>290</fpage>
          <lpage>297</lpage>
          <pub-id pub-id-type="doi">10.1097/01.TA.0000078882.11919.AF</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Rich PB, Douillet CD, Mahler SA et al (2003) Adenosine triphosphate is released during injurious mechanical ventilation and contributes to lung edema. J Trauma 55:290&#x2013;7 <pub-id pub-id-type="pmid">12913640</pub-id></citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Douillet</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>WP</given-names>
              <suffix>III</suffix>
            </name>
            <name>
              <surname>Zarzaur</surname>
              <given-names>BL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mechanical ventilation alters airway nucleotides and purinoceptors in lung and extrapulmonary organs</article-title>
          <source>Am J Respir Cell Mol Biol</source>
          <year>2005</year>
          <volume>32</volume>
          <fpage>52</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="doi">10.1165/rcmb.2004-0177OC</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Douillet CD, Robinson WP III, Zarzaur BL et al (2005) Mechanical ventilation alters airway nucleotides and purinoceptors in lung and extrapulmonary organs. Am J Respir Cell Mol Biol 32:52&#x2013;8 <pub-id pub-id-type="pmid">15388514</pub-id></citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <citation citation-type="other">Geary C, Akinbi HT, Korfhagen T et al Increased susceptibility of purinergic receptor deficient mice to lung infection with <italic>Pseudomonas aeruginosa</italic>. Am J Physiol 289:L890&#x2013;5</citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>CMP</given-names>
            </name>
            <name>
              <surname>Paradiso</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Schwab</surname>
              <given-names>U</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chronic airway infection/inflammation induces a Ca<sup>2+</sup> independent hyperinflammatory response in human cystic fibrosis airway epithelia</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <fpage>17798</fpage>
          <lpage>17806</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M410618200</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Ribeiro CMP, Paradiso AM, Schwab U et al (2005) Chronic airway infection/inflammation induces a Ca2+ independent hyperinflammatory response in human cystic fibrosis airway epithelia. J Biol Chem 280:17798&#x2013;806 <pub-id pub-id-type="pmid">15746099</pub-id></citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Denlinger</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Fisette</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Sommer</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cutting Edge: The nucleotide receptor P2X<sub>7</sub> contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide</article-title>
          <source>J Immunol</source>
          <year>2001</year>
          <volume>167</volume>
          <fpage>1871</fpage>
          <lpage>1876</lpage>
        </citation>
        <citation citation-type="display-unstructured">Denlinger LC, Fisette PL, Sommer JA et al (2001) Cutting Edge: The nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol 167:1871&#x2013;6 <pub-id pub-id-type="pmid">11489964</pub-id></citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perregaux</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>McNiff</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Laliberte</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATP Acts as an agonist to promote stimulus-induced secretion of IL-1&#x3B2; and IL-18 in human blood</article-title>
          <source>J Immunol</source>
          <year>2000</year>
          <volume>165</volume>
          <fpage>4615</fpage>
          <lpage>4623</lpage>
        </citation>
        <citation citation-type="display-unstructured">Perregaux DG, McNiff P, Laliberte R et al (2000) ATP Acts as an agonist to promote stimulus-induced secretion of IL-1&#x3B2; and IL-18 in human blood. J Immunol 165:4615&#x2013;23 <pub-id pub-id-type="pmid">11035104</pub-id></citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
          <article-title>Update in pulmonary medicine</article-title>
          <source>Clin Pediatr Med Surg</source>
          <year>2002</year>
          <volume>19</volume>
          <fpage>1</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="doi">10.1016/S0891-8422(03)00078-8</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Brown EA, Hoffmann SP (2002) Update in pulmonary medicine. Clin Pediatr Med Surg 19:1&#x2013;22 </citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Relationship of airway epithelial ion transport to chronic bronchitis</article-title>
          <source>Proc Am Thorac Soc</source>
          <year>2004</year>
          <volume>1</volume>
          <fpage>66</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.1513/pats.2306018</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Boucher RC (2004) Relationship of airway epithelial ion transport to chronic bronchitis. Proc Am Thorac Soc 1:66&#x2013;70. <pub-id pub-id-type="pmid">16113415</pub-id></citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sadikot</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Blackwell</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Christman</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Prince</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Pathogen-host interactions in <italic>Pseudomonas aeruginosa</italic> pneumonia</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>2005</year>
          <volume>171</volume>
          <fpage>1209</fpage>
          <lpage>1223</lpage>
          <pub-id pub-id-type="doi">10.1164/rccm.200408-1044SO</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Sadikot RT, Blackwell TS, Christman JW, Prince AS (2005) Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 171:1209&#x2013;23 <pub-id pub-id-type="pmid">15695491</pub-id></citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>North</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Surprenant</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Pharmacology of cloned P2X receptors</article-title>
          <source>Ann Rev Pharmacol Toxicol</source>
          <year>2000</year>
          <volume>40</volume>
          <fpage>563</fpage>
          <lpage>580</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.pharmtox.40.1.563</pub-id>
        </citation>
        <citation citation-type="display-unstructured">North RA, Surprenant A (2000) Pharmacology of cloned P2X receptors. Ann Rev Pharmacol Toxicol 40:563&#x2013;80 <pub-id pub-id-type="pmid">10836147</pub-id></citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Otero</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Garrad</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Velazquez</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mechanisms of agonist-dependent and -independent desensitization of a recombinant P2Y<sub>2</sub> nucleotide receptor</article-title>
          <source>Mol Cell Biochem</source>
          <year>2000</year>
          <volume>205</volume>
          <fpage>115</fpage>
          <lpage>123</lpage>
          <pub-id pub-id-type="doi">10.1023/A:1007018001735</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Otero M, Garrad R, Velazquez B et al (2000) Mechanisms of agonist-dependent and -independent desensitization of a recombinant P2Y2 nucleotide receptor. Mol Cell Biochem 205:115&#x2013;23 <pub-id pub-id-type="pmid">10821429</pub-id></citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kucher</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Neary</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Bi-functional effects of ATP/P2 receptor activation on tumor necrosis factor-alpha release in lipopolysaccharide-stimulated astrocytes</article-title>
          <source>J Neurochem</source>
          <year>2005</year>
          <volume>92</volume>
          <fpage>525</fpage>
          <lpage>535</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02885.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Kucher BM, Neary JT (2005) Bi-functional effects of ATP/P2 receptor activation on tumor necrosis factor-alpha release in lipopolysaccharide-stimulated astrocytes. J Neurochem 92:525&#x2013;35 <pub-id pub-id-type="pmid">15659223</pub-id></citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Picher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Biochemical evidence for an ecto alkaline phosphodiesterase I in human airways</article-title>
          <source>Am J Respir Cell Mol Biol</source>
          <year>2000</year>
          <volume>23</volume>
          <fpage>255</fpage>
          <lpage>261</lpage>
        </citation>
        <citation citation-type="display-unstructured">Picher M, Boucher RC (2000) Biochemical evidence for an ecto alkaline phosphodiesterase I in human airways. Am J Respir Cell Mol Biol 23:255&#x2013;61 <pub-id pub-id-type="pmid">10919994</pub-id></citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donaldson</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Lazarowski</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Picher</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Basal nucleotide levels, release, and metabolism in normal and cystic fibrosis airways</article-title>
          <source>Mol Med</source>
          <year>2000</year>
          <volume>6</volume>
          <fpage>969</fpage>
          <lpage>982</lpage>
        </citation>
        <citation citation-type="display-unstructured">Donaldson SH, Lazarowski ER, Picher M et al (2000) Basal nucleotide levels, release, and metabolism in normal and cystic fibrosis airways. Mol Med 6:969&#x2013;82 <pub-id pub-id-type="pmid">11147574</pub-id></citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lazarowski</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Harden</surname>
              <given-names>TK</given-names>
            </name>
          </person-group>
          <article-title>Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>31061</fpage>
          <lpage>31068</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M003255200</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Lazarowski ER, Boucher RC, Harden TK (2000) Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. J Biol Chem 275:31061&#x2013;8 <pub-id pub-id-type="pmid">10913128</pub-id></citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donaldson</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Picher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfaces</article-title>
          <source>Am J Respir Cell Mol Biol</source>
          <year>2002</year>
          <volume>26</volume>
          <fpage>209</fpage>
          <lpage>215</lpage>
        </citation>
        <citation citation-type="display-unstructured">Donaldson SH, Picher M, Boucher RC (2000) Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfaces. Am J Respir Cell Mol Biol 26:209&#x2013;15 <pub-id pub-id-type="pmid">11804872</pub-id></citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fortuna</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Carty</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Sajdeja</surname>
              <given-names>SW</given-names>
            </name>
          </person-group>
          <article-title>Enzymatic characterization of the matrix vesicle alkaline phosphatase isolated from bovine epiphyseal cartilage</article-title>
          <source>Calcif Tissue Int</source>
          <year>1980</year>
          <volume>30</volume>
          <fpage>217</fpage>
          <lpage>225</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02408631</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Fortuna R, Anderson HC, Carty RP, Sajdeja SW (1980) Enzymatic characterization of the matrix vesicle alkaline phosphatase isolated from bovine epiphyseal cartilage. Calcif Tissue Int 30:217&#x2013;25 <pub-id pub-id-type="pmid">6772288</pub-id></citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmermann</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Extracellular metabolism of ATP and other nucleotides</article-title>
          <source>Naunyn-Schmiedeberg&#x2019;s Arch Pharmacol</source>
          <year>2000</year>
          <volume>362</volume>
          <fpage>299</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="doi">10.1007/s002100000309</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmiedeberg&#x2019;s Arch Pharmacol 362:299&#x2013;309 </citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Plesner</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Ecto-ATPases: Identities and functions</article-title>
          <source>Int Rev Cytol</source>
          <year>1995</year>
          <volume>158</volume>
          <fpage>141</fpage>
          <lpage>214</lpage>
          <pub-id pub-id-type="doi">10.1016/S0074-7696(08)62487-0</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Plesner L (1995) Ecto-ATPases: Identities and functions. Int Rev Cytol 158:141&#x2013;214 <pub-id pub-id-type="pmid">7721538</pub-id></citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leal</surname>
              <given-names>DBR</given-names>
            </name>
            <name>
              <surname>Streher</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Neu</surname>
              <given-names>TN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization of NTPDase (NTPDase 1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2005</year>
          <volume>1721</volume>
          <fpage>9</fpage>
          <lpage>15</lpage>
        </citation>
        <citation citation-type="display-unstructured">Leal DBR, Streher CA, Neu TN et al (2005) Characterization of NTPDase (NTPDase 1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes. Biochim Biophys Acta 1721:9&#x2013;15 <pub-id pub-id-type="pmid">15652174</pub-id></citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Kirley</surname>
              <given-names>TL</given-names>
            </name>
          </person-group>
          <article-title>Cloning, sequencing and expression of a human brain ecto-apyrase related to both the ecto-ATPase and CD39 ecto-apyrase 1</article-title>
          <source>Biochim Biophys Acta</source>
          <year>1998</year>
          <volume>1386</volume>
          <fpage>65</fpage>
          <lpage>78</lpage>
        </citation>
        <citation citation-type="display-unstructured">Smith TM, Kirley TL (1998) Cloning, sequencing and expression of a human brain ecto-apyrase related to both the ecto-ATPase and CD39 ecto-apyrase 1. Biochim Biophys Acta 1386:65&#x2013;78 <pub-id pub-id-type="pmid">9675246</pub-id></citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shi</surname>
              <given-names>XJ</given-names>
            </name>
            <name>
              <surname>Knowles</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of the mercurial-sensitive ectoATPase in human small cell lung carcinoma: Characterization and partial purification</article-title>
          <source>Arch Biochem Biophys</source>
          <year>1994</year>
          <volume>315</volume>
          <fpage>177</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="doi">10.1006/abbi.1994.1487</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Shi XJ, Knowles AF (1994) Prevalence of the mercurial-sensitive ectoATPase in human small cell lung carcinoma: Characterization and partial purification. Arch Biochem Biophys 315:177&#x2013;84 <pub-id pub-id-type="pmid">7979396</pub-id></citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sevigny</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Robson</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Waelkens</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification and characterization of a novel hepatic canalicular ATP diphosphohydrolase</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>5640</fpage>
          <lpage>5647</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.275.8.5640</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Sevigny J, Robson SC, Waelkens E et al (2000) Identification and characterization of a novel hepatic canalicular ATP diphosphohydrolase. J Biol Chem 275:5640&#x2013;7 <pub-id pub-id-type="pmid">10681547</pub-id></citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chadwick</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Frischauf</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>The CD39-like gene family: Identification of three new human members (CD39L2, CD39L3, and CD39L4), their murine homologues, and a member of the gene family from <italic>Drosophila melanogaster</italic></article-title>
          <source>Genomics</source>
          <year>1998</year>
          <volume>50</volume>
          <fpage>357</fpage>
          <lpage>367</lpage>
          <pub-id pub-id-type="doi">10.1006/geno.1998.5317</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Chadwick BP, Frischauf AM (1998). The CD39-like gene family: Identification of three new human members (CD39L2, CD39L3, and CD39L4), their murine homologues, and a member of the gene family from Drosophila melanogaster. Genomics 50:357&#x2013;67 <pub-id pub-id-type="pmid">9676430</pub-id></citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Picher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Button</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Therapeutic potential of ebselen for nucleotide-mediated mucociliary clearance in the lungs of cystic fibrosis patients</article-title>
          <source>Pediatr Pulmonol</source>
          <year>2005</year>
          <volume>28</volume>
          <fpage>274</fpage>
        </citation>
        <citation citation-type="display-unstructured">Picher M, Button B, Boucher R (2005) Therapeutic potential of ebselen for nucleotide-mediated mucociliary clearance in the lungs of cystic fibrosis patients. Pediatr Pulmonol 28:274. </citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kukulski</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Levesque</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Lavoie</surname>
              <given-names>EG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparative hydrolysis of P2 receptor agonists by NTPDase 1, 2, 3 and 8</article-title>
          <source>Purin Signal</source>
          <year>2005</year>
          <volume>1</volume>
          <fpage>193</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="doi">10.1007/s11302-005-6217-x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Kukulski F, Levesque SA, Lavoie EG et al (2005) Comparative hydrolysis of P2 receptor agonists by NTPDase 1, 2, 3 and 8. Purin Signal 1:193&#x2013;204 </citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Button</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Picher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lazarowski</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Sustained release and accumulation of nucleotides during cyclic compressive stress increases mucus clearance in CF human airway epithelial surfaces</article-title>
          <source>Pediatr Pulmonol</source>
          <year>2004</year>
          <volume>27</volume>
          <fpage>213</fpage>
        </citation>
        <citation citation-type="display-unstructured">Button B, Picher M, Lazarowski E, Boucher RC (2004) Sustained release and accumulation of nucleotides during cyclic compressive stress increases mucus clearance in CF human airway epithelial surfaces. Pediatr Pulmonol 27:213 </citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>App</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Kieselmann</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Reinhardt</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: Flutter vs autogenic drainage</article-title>
          <source>Chest</source>
          <year>1998</year>
          <volume>114</volume>
          <fpage>171</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="doi">10.1378/chest.114.1.171</pub-id>
        </citation>
        <citation citation-type="display-unstructured">App EM, Kieselmann R, Reinhardt D et al (1998) Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: Flutter vs autogenic drainage. Chest 114:171&#x2013;7 <pub-id pub-id-type="pmid">9674466</pub-id></citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenfeld</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ramsey</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title><italic>Pseudomonas</italic> acquisition in young patients with cystic fibrosis: Pathophysiology, diagnosis and management</article-title>
          <source>Curr Opin Pulm Med</source>
          <year>2003</year>
          <volume>9</volume>
          <fpage>492</fpage>
          <lpage>497</lpage>
          <pub-id pub-id-type="doi">10.1097/00063198-200311000-00008</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Rosenfeld M, Ramsey B, Gibson R (2003) Pseudomonas acquisition in young patients with cystic fibrosis: Pathophysiology, diagnosis and management. Curr Opin Pulm Med 9:492&#x2013;7 <pub-id pub-id-type="pmid">14534401</pub-id></citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Picher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Burch</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Expression of alkaline phosphatase and ecto 5&#x2019;-nucleotidase (CD73) in normal and CF airway epithelia</article-title>
          <source>Pediatr Pulmonol</source>
          <year>2000</year>
          <volume>21</volume>
          <fpage>227</fpage>
        </citation>
        <citation citation-type="display-unstructured">Picher M, Burch LH, Boucher RC (2000) Expression of alkaline phosphatase and ecto 5&#x2019;-nucleotidase (CD73) in normal and CF airway epithelia. Pediatr Pulmonol 21:227 </citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Picher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Detoxification of <italic>Pseudomonas aeruginosa</italic> lipopolysaccharide in human airways: An inflammatory response mediated by non-specific alkaline phosphatase</article-title>
          <source>Pediatr Pulmonol</source>
          <year>2003</year>
          <volume>Suppl. 25</volume>
          <fpage>271</fpage>
        </citation>
        <citation citation-type="display-unstructured">Picher M, Boucher RC (2003) Detoxification of Pseudomonas aeruginosa lipopolysaccharide in human airways: An inflammatory response mediated by non-specific alkaline phosphatase. Pediatr Pulmonol Suppl. 25:271 </citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>MacNee</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease</article-title>
          <source>Proc Am Thorac Soc</source>
          <year>2005</year>
          <volume>2</volume>
          <fpage>50</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1513/pats.200411-056SF</pub-id>
        </citation>
        <citation citation-type="display-unstructured">MacNee W (2005) Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:50&#x2013;60 <pub-id pub-id-type="pmid">16113469</pub-id></citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rochelle</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Adler</surname>
              <given-names>KB</given-names>
            </name>
          </person-group>
          <article-title>Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells <italic>in vitro</italic></article-title>
          <source>Free Radic Biol Med</source>
          <year>1998</year>
          <volume>24</volume>
          <fpage>863</fpage>
          <lpage>868</lpage>
          <pub-id pub-id-type="doi">10.1016/S0891-5849(97)00375-4</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Rochelle LG, Fischer BM, Adler KB (1998) Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Radic Biol Med 24:863&#x2013;8 <pub-id pub-id-type="pmid">9586818</pub-id></citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zinchuk</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Okada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Seguchi</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Lipopolysaccharide alters ecto-ATP-diphosphohydrolase and causes relocation of its reaction product in experimental intrahepatic cholestasis</article-title>
          <source>Cell Tissue Res</source>
          <year>2001</year>
          <volume>304</volume>
          <fpage>103</fpage>
          <lpage>109</lpage>
          <pub-id pub-id-type="doi">10.1007/s004410000339</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Zinchuk VS, Okada T, Seguchi H (2001) Lipopolysaccharide alters ecto-ATP-diphosphohydrolase and causes relocation of its reaction product in experimental intrahepatic cholestasis. Cell Tissue Res 304:103&#x2013;9 <pub-id pub-id-type="pmid">11383876</pub-id></citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Faas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schuiling</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Valkhof</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Superoxide-mediated glomerulopathy in the endotoxin-treated pregnant rat</article-title>
          <source>Kidney Blood Press Res</source>
          <year>1998</year>
          <volume>21</volume>
          <fpage>432</fpage>
          <lpage>437</lpage>
          <pub-id pub-id-type="doi">10.1159/000025896</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Faas M, Schuiling G, Valkhof N et al (1998) Superoxide-mediated glomerulopathy in the endotoxin-treated pregnant rat. Kidney Blood Press Res 21:432&#x2013;7 <pub-id pub-id-type="pmid">9933828</pub-id></citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krotz</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sohn</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Keller</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Depolarization of endothelial cells enhances platelet aggregation through oxidative inactivation of endothelial NTPDase</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <year>2002</year>
          <volume>22</volume>
          <fpage>2003</fpage>
          <lpage>2009</lpage>
          <pub-id pub-id-type="doi">10.1161/01.ATV.0000043454.08172.51</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Krotz F, Sohn HY, Keller M et al (2002) Depolarization of endothelial cells enhances platelet aggregation through oxidative inactivation of endothelial NTPDase. Arterioscler Thromb Vasc Biol 22:2003&#x2013;9 <pub-id pub-id-type="pmid">12482826</pub-id></citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Candinas</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Koyamada</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Miyatake</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Loss of rat glomerular ATP diphosphohydrolase activity during reperfusion injury is associated with oxidative stress reactions</article-title>
          <source>Thromb Haemost</source>
          <year>1996</year>
          <volume>76</volume>
          <fpage>807</fpage>
          <lpage>812</lpage>
        </citation>
        <citation citation-type="display-unstructured">Candinas D, Koyamada N, Miyatake T et al (1996) Loss of rat glomerular ATP diphosphohydrolase activity during reperfusion injury is associated with oxidative stress reactions. Thromb Haemost 76:807&#x2013;12 <pub-id pub-id-type="pmid">8950794</pub-id></citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robson</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Kaczmarek</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>JB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Loss of ATP diphosphohydrolase activity with endothelial cell activation</article-title>
          <source>J Exp Med</source>
          <year>1997</year>
          <volume>185</volume>
          <fpage>153</fpage>
          <lpage>164</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.185.1.153</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Robson SC, Kaczmarek E, Siegel JB et al (1997) Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 185:153&#x2013;64 <pub-id pub-id-type="pmid">8996251</pub-id></citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalmar</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kittel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lemmens</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cultured astrocytes react to LPS with increased cyclooxygenase activity and phagocytosis</article-title>
          <source>Neurochem Int</source>
          <year>2001</year>
          <volume>38</volume>
          <fpage>453</fpage>
          <lpage>461</lpage>
          <pub-id pub-id-type="doi">10.1016/S0197-0186(00)00090-5</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Kalmar B, Kittel A, Lemmens R et al (2001) Cultured astrocytes react to LPS with increased cyclooxygenase activity and phagocytosis. Neurochem Int 38:453&#x2013;61 <pub-id pub-id-type="pmid">11222926</pub-id></citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kapojos</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Poelstra</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Borghuis</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Induction of glomerular alkaline phosphatase after challenge with lipopolysaccharide</article-title>
          <source>Int J Exp Pathol</source>
          <year>2003</year>
          <volume>84</volume>
          <fpage>135</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2613.2003.00345.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Kapojos JJ, Poelstra K, Borghuis T et al (2003) Induction of glomerular alkaline phosphatase after challenge with lipopolysaccharide. Int J Exp Pathol 84:135&#x2013;44 <pub-id pub-id-type="pmid">12974943</pub-id></citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zinchuk</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Seguchi</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Lipopolysaccharide administration increases acid and alkaline phosphatase reactivity in the cardiac muscle</article-title>
          <source>Microsc Res Tech</source>
          <year>2002</year>
          <volume>58</volume>
          <fpage>421</fpage>
          <lpage>426</lpage>
          <pub-id pub-id-type="doi">10.1002/jemt.10156</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Okada T, Zinchuk VS, Seguchi H (2002) Lipopolysaccharide administration increases acid and alkaline phosphatase reactivity in the cardiac muscle. Microsc Res Tech 58:421&#x2013;6 <pub-id pub-id-type="pmid">12226812</pub-id></citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Braun</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Krieglstein</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Up-regulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat</article-title>
          <source>J Neurosci</source>
          <year>1998</year>
          <volume>18</volume>
          <fpage>4891</fpage>
          <lpage>4900</lpage>
        </citation>
        <citation citation-type="display-unstructured">Braun N, Zhu Y, Krieglstein J et al (1998) Up-regulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J Neurosci 18:4891&#x2013;900 <pub-id pub-id-type="pmid">9634555</pub-id></citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pier</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Grout</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zaidi</surname>
              <given-names>TS</given-names>
            </name>
          </person-group>
          <article-title>Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of <italic>Pseudomonas aeruginosa</italic> from the lung</article-title>
          <source>Proc Natl Acad Sci</source>
          <year>1997</year>
          <volume>94</volume>
          <fpage>12088</fpage>
          <lpage>12093</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.94.22.12088</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Pier GB, Grout M, Zaidi TS (1997) Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci 94:12088&#x2013;93 <pub-id pub-id-type="pmid">9342367</pub-id></citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schroeder</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Yacono</surname>
              <given-names>PW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CFTR is a pattern recognition molecule that extracts <italic>Pseudomonas aeruginosa</italic> LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation</article-title>
          <source>Proc Natl Acad Sci</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>6907</fpage>
          <lpage>6912</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.092160899</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Schroeder TH, Lee MM, Yacono PW et al (2002) CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation. Proc Natl Acad Sci 99:6907&#x2013;12 <pub-id pub-id-type="pmid">11997458</pub-id></citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kikuchi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hagiwara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Clarithromycin</italic> suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-{kappa}B transcription factors</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2002</year>
          <volume>49</volume>
          <fpage>745</fpage>
          <lpage>755</lpage>
          <pub-id pub-id-type="doi">10.1093/jac/dkf008</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Kikuchi T, Hagiwara K, Honda Y et al (2002) Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-{kappa}B transcription factors. J Antimicrob Chemother 49:745&#x2013;55 <pub-id pub-id-type="pmid">12003967</pub-id></citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pier</surname>
              <given-names>GB</given-names>
            </name>
          </person-group>
          <article-title>CFTR mutations and host susceptibility to <italic>Pseudomonas aeruginosa</italic> lung infection</article-title>
          <source>Curr Opin Microbiol</source>
          <year>2002</year>
          <volume>5</volume>
          <fpage>81</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="doi">10.1016/S1369-5274(02)00290-4</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Pier GB (2002) CFTR mutations and host susceptibility to Pseudomonas aeruginosa lung infection. Curr Opin Microbiol 5:81&#x2013;6 <pub-id pub-id-type="pmid">11834374</pub-id></citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Voynow</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Malarkey</surname>
              <given-names>DE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neutrophil elastase induces mucus cell metaplasia in mouse lung</article-title>
          <source>Am J Physiol</source>
          <year>2004</year>
          <volume>287</volume>
          <fpage>L1293</fpage>
          <lpage>L1302</lpage>
        </citation>
        <citation citation-type="display-unstructured">Voynow JA, Fischer BM, Malarkey DE et al (2004) Neutrophil elastase induces mucus cell metaplasia in mouse lung. Am J Physiol 287:L1293&#x2013;302 </citation>
      </ref>
    </ref-list>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ADP</term>
          <def>
            <p>adenosine 5&#x2019;-diphosphate</p>
          </def>
        </def-item>
        <def-item>
          <term>AMP</term>
          <def>
            <p>adenosine 5&#x2019;-monophosphate</p>
          </def>
        </def-item>
        <def-item>
          <term>ATP</term>
          <def>
            <p>adenosine 5&#x2019;-triphosphate</p>
          </def>
        </def-item>
        <def-item>
          <term>ASL</term>
          <def>
            <p>airway surface liquid</p>
          </def>
        </def-item>
        <def-item>
          <term>MCC</term>
          <def>
            <p>mucociliary clearance</p>
          </def>
        </def-item>
        <def-item>
          <term>CCS</term>
          <def>
            <p>cyclic compressive stress</p>
          </def>
        </def-item>
        <def-item>
          <term>CF</term>
          <def>
            <p>cystic fibrosis</p>
          </def>
        </def-item>
        <def-item>
          <term>CFTR</term>
          <def>
            <p>cystic fibrosis transmembrane regulator</p>
          </def>
        </def-item>
        <def-item>
          <term>ENAC</term>
          <def>
            <p>epithelial sodium channel</p>
          </def>
        </def-item>
        <def-item>
          <term>IL-1&#x3B2;</term>
          <def>
            <p>interleukin-1beta</p>
          </def>
        </def-item>
        <def-item>
          <term>IL-8</term>
          <def>
            <p>interleukin-8</p>
          </def>
        </def-item>
        <def-item>
          <term>LPS</term>
          <def>
            <p>lipopolysaccharide</p>
          </def>
        </def-item>
        <def-item>
          <term>MCC</term>
          <def>
            <p>mucociliary clearance</p>
          </def>
        </def-item>
        <def-item>
          <term>NS AP</term>
          <def>
            <p>non-specific alkaline phosphatase</p>
          </def>
        </def-item>
        <def-item>
          <term>PCL</term>
          <def>
            <p>periciliary liquid</p>
          </def>
        </def-item>
        <def-item>
          <term>PCR</term>
          <def>
            <p>polymerase chain reaction</p>
          </def>
        </def-item>
        <def-item>
          <term>TNF&#x3B1;</term>
          <def>
            <p>tumor necrosis factor alpha</p>
          </def>
        </def-item>
        <def-item>
          <term>UTP</term>
          <def>
            <p>uridine 5&#x2019;-triphosphate</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
  </back>
</article>
</pmc-articleset>